169 related articles for article (PubMed ID: 30105069)
1. Gypenosides Altered Hepatic Bile Acids Homeostasis in Mice Treated with High Fat Diet.
Lu Y; Du Y; Qin L; Wu D; Wang W; Ling L; Ma F; Ling H; Yang L; Wang C; Wang Z; Zhou X; He Y
Evid Based Complement Alternat Med; 2018; 2018():8098059. PubMed ID: 30105069
[TBL] [Abstract][Full Text] [Related]
2. Alkaloids of dendrobium nobile lindl. Altered hepatic lipid homeostasis via regulation of bile acids.
Huang S; Wu Q; Liu H; Ling H; He Y; Wang C; Wang Z; Lu Y; Lu Y
J Ethnopharmacol; 2019 Sep; 241():111976. PubMed ID: 31132462
[TBL] [Abstract][Full Text] [Related]
3. Multi‑omics‑based analysis of the regulatory mechanism of gypenosides on bile acids in hypercholesterolemic mice.
Feng C; Yang Y; Lu A; Tan D; Lu Y; Qin L; He Y
Exp Ther Med; 2023 Sep; 26(3):438. PubMed ID: 37614436
[No Abstract] [Full Text] [Related]
4. Gypenosides regulate farnesoid X receptor-mediated bile acid and lipid metabolism in a mouse model of non-alcoholic steatohepatitis.
Li H; Xi Y; Xin X; Tian H; Hu Y
Nutr Metab (Lond); 2020; 17():34. PubMed ID: 32377219
[TBL] [Abstract][Full Text] [Related]
5. Liver lipidomics analysis reveals the anti-obesity and lipid-lowering effects of gypnosides from heat-processed Gynostemma pentaphyllum in high-fat diet fed mice.
Xie P; Xie JB; Xiao MY; Guo M; Qi YS; Li FF; Piao XL
Phytomedicine; 2023 Jul; 115():154834. PubMed ID: 37094422
[TBL] [Abstract][Full Text] [Related]
6. Effects of heat-processed Gynostemma pentaphyllum on high-fat diet-fed mice of obesity and functional analysis on network pharmacology and molecular docking strategy.
Xie P; Guo M; Xie JB; Xiao MY; Qi YS; Duan Y; Li FF; Piao XL
J Ethnopharmacol; 2022 Aug; 294():115335. PubMed ID: 35513215
[TBL] [Abstract][Full Text] [Related]
7. Gypenosides ameliorate high-fat diet-induced nonalcoholic fatty liver disease in mice by regulating lipid metabolism.
Zhou T; Cao L; Du Y; Qin L; Lu Y; Zhang Q; He Y; Tan D
PeerJ; 2023; 11():e15225. PubMed ID: 37065701
[TBL] [Abstract][Full Text] [Related]
8. Gypenosides ameliorate high-fat diet-induced non-alcoholic steatohepatitis
Li H; Xi Y; Liu H; Xin X
Front Nutr; 2022; 9():914079. PubMed ID: 36091227
[TBL] [Abstract][Full Text] [Related]
9. Protective effects of gypenosides against fatty liver disease induced by high fat and cholesterol diet and alcohol in rats.
Qin R; Zhang J; Li C; Zhang X; Xiong A; Huang F; Yin Z; Li K; Qin W; Chen M; Zhang S; Liang L; Zhang H; Nie H; Ye W
Arch Pharm Res; 2012 Jul; 35(7):1241-50. PubMed ID: 22864747
[TBL] [Abstract][Full Text] [Related]
10. Gypenosides Prevent and Dissolve Cholesterol Gallstones by Modulating the Homeostasis of Cholesterol and Bile Acids.
Zhuang Q; Cheng J; Xia J; Ning M; Wu S; Shen S; Shi Y; Huang D; Dong Z; Wan X
Front Med (Lausanne); 2022; 9():818144. PubMed ID: 35445045
[TBL] [Abstract][Full Text] [Related]
11. The hypocholesterolemic activity of Momordica charantia fruit is mediated by the altered cholesterol- and bile acid-regulating gene expression in rat liver.
Matsui S; Yamane T; Takita T; Oishi Y; Kobayashi-Hattori K
Nutr Res; 2013 Jul; 33(7):580-5. PubMed ID: 23827133
[TBL] [Abstract][Full Text] [Related]
12. Ablation of gut microbiota alleviates obesity-induced hepatic steatosis and glucose intolerance by modulating bile acid metabolism in hamsters.
Sun L; Pang Y; Wang X; Wu Q; Liu H; Liu B; Liu G; Ye M; Kong W; Jiang C
Acta Pharm Sin B; 2019 Jul; 9(4):702-710. PubMed ID: 31384531
[TBL] [Abstract][Full Text] [Related]
13. Medium-chain fatty acids reduce serum cholesterol by regulating the metabolism of bile acid in C57BL/6J mice.
Liu Y; Zhang Y; Zhang X; Xu Q; Yang X; Xue C
Food Funct; 2017 Jan; 8(1):291-298. PubMed ID: 28009872
[TBL] [Abstract][Full Text] [Related]
14. Endogenously synthesized n-3 polyunsaturated fatty acids in fat-1 mice ameliorate high-fat diet-induced non-alcoholic fatty liver disease.
Kim EH; Bae JS; Hahm KB; Cha JY
Biochem Pharmacol; 2012 Nov; 84(10):1359-65. PubMed ID: 22981383
[TBL] [Abstract][Full Text] [Related]
15. All-trans retinoic acid regulates hepatic bile acid homeostasis.
Yang F; He Y; Liu HX; Tsuei J; Jiang X; Yang L; Wang ZT; Wan YJ
Biochem Pharmacol; 2014 Oct; 91(4):483-9. PubMed ID: 25175738
[TBL] [Abstract][Full Text] [Related]
16. Dietary fat and gut microbiota interactions determine diet-induced obesity in mice.
Kübeck R; Bonet-Ripoll C; Hoffmann C; Walker A; Müller VM; Schüppel VL; Lagkouvardos I; Scholz B; Engel KH; Daniel H; Schmitt-Kopplin P; Haller D; Clavel T; Klingenspor M
Mol Metab; 2016 Dec; 5(12):1162-1174. PubMed ID: 27900259
[TBL] [Abstract][Full Text] [Related]
17. Loperamide induces excessive accumulation of bile acids in the liver of mice with different diets.
Lei Z; Rong H; Yang Y; Yu S; Zhang T; Chen L; Nie Y; Song Q; Hu Q; Guo J
Toxicology; 2022 Jul; 477():153278. PubMed ID: 35926757
[TBL] [Abstract][Full Text] [Related]
18. Lactoferrin promotes bile acid metabolism and reduces hepatic cholesterol deposition by inhibiting the farnesoid X receptor (FXR)-mediated enterohepatic axis.
Ling CJ; Xu JY; Li YH; Tong X; Yang HH; Yang J; Yuan LX; Qin LQ
Food Funct; 2019 Nov; 10(11):7299-7307. PubMed ID: 31626262
[TBL] [Abstract][Full Text] [Related]
19. [Intervention of Catalpol on High-fat Diet Induced Nonalcoholic Fatty Liver Disease in Mice].
Tian X; Xiong Q; Chen L; Wen JR; Ru Q
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2019 Dec; 41(6):746-755. PubMed ID: 31907123
[No Abstract] [Full Text] [Related]
20. Trimethylamine-N-oxide (TMAO)-induced atherosclerosis is associated with bile acid metabolism.
Ding L; Chang M; Guo Y; Zhang L; Xue C; Yanagita T; Zhang T; Wang Y
Lipids Health Dis; 2018 Dec; 17(1):286. PubMed ID: 30567573
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
